Back to 
Capital International, Inc.
Capital International, Inc.
TEVA
Showing 0 of 16 quarters
Position history for Capital International, Inc.'s holdings in Teva Pharmaceutical Industries Limited
No. Capital International exited its TEVA (Teva Pharmaceutical Industries) position in Q4 2023. Its Q3 2023 13F listed 24,359 shares worth $248,462. Capital International first reported TEVA in Q1 2020 and held it in 15 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of TEVA: BlackRock, Inc., Capital Research Global Investors